Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir

Raltegravir is a novel human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor with potent in vitro activity against HIV-1 (95% inhibitory concentration = 31 nM in 50% human serum). The possible effects of ritonavir and efavirenz on raltegravir pharmacokinetics were separatel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Iwamoto, Marian, Wenning, Larissa A., Petry, Amelia S., Laethem, Martine, De Smet, Marina, Kost, James T., Breidinger, Sheila A., Mangin, Eric C., Azrolan, Neal, Greenberg, Howard E., Haazen, Wouter, Stone, Julie A., Gottesdiener, Keith M., Wagner, John A.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2008
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2592871/
https://ncbi.nlm.nih.gov/pubmed/18838589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01543-07
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars